Several sero-epidemiological studies have associated P. falciparum antigen-specific cytophilic immunoglobulin (Ig) G (particularly IgG1 and IgG3) with protection from clinical malaria [2]–[4] suggesting a critical role for immune effector cells in malaria immunity. This evidence concerns the gene IGHG3 and malaria.